Mitral Valve Disease Market Is Expected to Generate $5.7 Billion by 2031: Allied Market Research

<!– Name:DistributionId Value:8824015 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1098508 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:1a055457-1021-40db-a03e-c9e1b734f4a2 –>

Portland, OR, April 24, 2023 (GLOBE NEWSWIRE) — According to the report published by allied Market Research, the global mitral valve disease market garnered $2.5 billion in 2021, and is estimated to generate $5.7 billion by 2031, manifesting a CAGR of 8.8% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market. 

Request Sample Report- https://www.alliedmarketresearch.com/request-sample/74863

Report coverage & details: 

Impact of Covid-19 on Mitral Valve Disease Market:   

• The outbreak of the COVID-19 pandemic had a negative impact on the global mitral valve disease market, owing to the reduction of patient visits to the hospital for treatment of diseases other than COVID-19.  
• Furthermore, the decline in the number of surgeries performed globally also negatively impacted the market growth. 
• Post pandemic, the mitral valve disease industry is slowly recovering and is expected to grow significantly as the healthcare sector is adapting to improved treatment techniques. 

Procure Complete Report (374 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/mitral-valve-disease-market

The research provides detailed segmentation of the global mitral valve disease market based on treatment type, indication, end user, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report. 

Based on treatment type, the mitral valve repair segment held the highest share in 2021, accounting for more than half of the global mitral valve disease market and is expected to continue its leadership status during the forecast period. However, the mitral valve replacement segment is expected to register the highest CAGR of 11.0% from 2022 to 2031. 

By indication, the mitral valve regurgitation segment accounted for the highest share in 2021, contributing to more than two-thirds of the global mitral valve disease market and is expected to maintain its lead in terms of revenue during the forecast period. However, the mitral valve stenosis segment is expected to manifest the highest CAGR of 9.7% from 2022 to 2031. 

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/74863

On the basis of end user, the hospitals segment held the highest share in 2021, accounting for nearly three-fifths of the global mitral valve disease market and is expected to continue its leadership status during the forecast period. The same segment is expected to manifest the highest CAGR of 9.2% from 2022 to 2031. 

Based on region, North America held the largest share in 2021, contributing to more than two-fifths of the global mitral valve disease market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 9.8% during the forecast period. 

Leading market players of the global mitral valve disease market analyzed in the research,

• Zydus Lifesciences Limited
• Valcare Medical
• Novartis AG
• Medtronic plc
• Braile Biomedica
• Labcor Laboratorios Ltda
• Edwards Lifesciences Corporation
• Bayer AG
• Affluent Medical
• Corcym UK Limited
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• ShockWave Medical Inc.
• Artivion Inc.
• Abbott Laboratories.

The report provides a detailed analysis of these key players of the global mitral valve disease market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry-

Medical Gas Analyzers Market Expected to Reach $325 Million by 2025

Antibiotics Market Expected to Reach $50,374 Million by 2025

Healthcare Chatbot Market Expected to Reach $116.9 Million by 2026

Pharmaceutical Filtration Market Expected to Reach $7.74 Billion by 2026

Drug Delivery Devices Market Expected to Reach $26.7 Billion by 2026

Artificial Cornea and Corneal Implant Market Expected to Reach $656.19 Million by 2028

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter